$ISPC just crushed a large-scale international cancer order hundreds of specimens shipped in only 3 weeks.
Sitting right on the 52w low ~$1.70 after the drop. Follow-up PR looking very possible in the next 3 weeks.
Bio boom week is live $MRNA $HOWL $JUNS all running wild. Who else is watching ?
$ISPC just dropped a solid operational win completed a large-scale international cancer research order with hundreds of specimens sourced through their network and shipped within only 3 weeks of the PO.
Stock got sold off hard and is sitting right around the 52-week low near $1.70. Classic microcap reaction, but the timeline they highlighted makes a follow-up PR (delivery confirmation or revenue recognition) look pretty realistic in the next few weeks.
Meanwhile the broader bio space is on fire this week $MRNA $HOWL $JUNS all running wild. Watching $ISPC for any next catalyst and seeing if it can catch some of that momentum
$ISPC runs a global online marketplace that connects researchers with hospitals and labs to source human biospecimens (blood, tissue, tumor cells, etc.) for medical research.
Think of it as the “Amazon” for medical samples. Instead of researchers spending months cold-calling clinics one by one, they log into one portal, search, and get matched.
The platform uses smart algorithms to clean and harmonize complex patient data so scientists can pull exactly the sample characteristics they need — especially useful for training AI models.
Need real human blood samples for a new cancer drug? Just go on iSpecimen, select what you want, and they source it from their worldwide network.
While the bigger names are ripping this week $MRNA $HOWL $JUNS :
$ISPC quietly proving it can execute at scale